NovaSterilis, a leading innovator in medical device sterilization using supercritical carbon dioxide (“scCO2”), announces a collaboration with Dr. Jason Spector, M.D., Professor of Surgery and Chief of the Division of Plastic and Reconstructive Surgery at Weill Cornell Medicine, through New York State’s Center for Advanced Technology (CAT) grant program. NovaSterilis and Dr. Spector’s research group will embark on an important regenerative medicine research initiative. This collaboration brings together NovaSterilis’ deep expertise of decellularization and terminal sterilization of medical devices in their final packaging, using scCO2 technologies and Dr. Spector’s extensive experience in plastic and reconstructive surgery.
NovaSterilis, a leading innovator in medical device sterilization using supercritical carbon dioxide (“scCO2”), is proud to announce its collaboration with Dr. Jason Spector, M.D., Professor of Surgery and Chief of the Division of Plastic and Reconstructive Surgery at Weill Cornell Medicine, through New York State’s Center for Advanced Technology (CAT) grant program.
Together, NovaSterilis and Dr. Spector’s research group will embark on an important regenerative medicine research initiative titled “Fabrication of a Decellularized Allograft Adipose Matrix Using Supercritical Carbon Dioxide for Soft Tissue Defect Repair and Regeneration.”
“We are thrilled to collaborate with Dr. Spector on this exciting project,” said Tony Eisenhut, CEO of NovaSterilis. “Our combined efforts have the potential to make a significant impact in regenerative medicine, ultimately benefiting patients and reducing costs associated with multiple treatments.
This collaboration brings together NovaSterilis’ deep expertise of decellularization and terminal sterilization of medical devices in their final packaging, using scCO2 technologies and Dr. Spector’s extensive experience in plastic and reconstructive surgery.
